Moreover, CCL5-CCR5 signaling provided resistance to apoptosis in T cells while enhancing T cell proliferation and cytokine production [33], potentially contributing to the persistent immune activation observed in AIH, even following immunosuppressive therapy in this study. This evidence concerns the gene CCL5 and autoimmune hepatitis.